The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
‘ASIA’ – Autoimmune/inflammatory syndrome induced by adjuvants
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hornung, V., Bauernfeind, F., Halle, A., Samstad, E. O., Kono, H., Rock, K. L., Fitzgerald, K. A., & Latz, E. (2008) · Nature Immunology · doi:10.1038/ni.1631 · Cited by 3,065
Development of Autoantibodies before the Clinical Onset of Systemic Lupus Erythematosus
Arbuckle, M. R., McClain, M. T., Rubertone, M. V., Scofield, R. H., Dennis, G. J., James, J. A., & Harley, J. B. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021933 · Cited by 2,578
Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants
Eisenbarth, S. C., Colegio, O. R., O’Connor, W., Sutterwala, F. S., & Flavell, R. A. (2008) · Nature · doi:10.1038/nature06939 · Cited by 1,542
Kool, M., Soullié, T., van Nimwegen, M., Willart, M. A. M., Muskens, F., Jung, S., Hoogsteden, H. C., Hammad, H., & Lambrecht, B. N. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20071087 · Cited by 993
Towards an understanding of the adjuvant action of aluminium
Marrack, P., McKee, A. S., & Munks, M. W. (2009) · Nature Reviews Immunology · doi:10.1038/nri2510 · Cited by 887 · cited 2×
“In doing so, aluminium stimulates the production and secretion of cytokines such as IL-1b; IL-18 and IL-33 [14].”
BackgroundThe Guillain–Barré Syndrome and the 1992–1993 and 1993–1994 Influenza Vaccines
Lasky, T., Terracciano, G. J., Magder, L., Koski, C. L., Ballesteros, M., Nash, D., Clark, S., Haber, P., Stolley, P. D., Schonberger, L. B., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199812173392501 · Cited by 505
Janowsky, E. C., Kupper, L. L., & Hulka, B. S. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003163421105 · Cited by 429
Infections and autoimmunity – friends or foes?
Kivity, S., Agmon-Levin, N., Blank, M., & Shoenfeld, Y. (2009) · Trends in Immunology · doi:10.1016/j.it.2009.05.005 · Cited by 397
Self-citationMcKee, A. S., Munks, M. W., MacLeod, M. K. L., Fleenor, C. J., Van Rooijen, N., Kappler, J. W., & Marrack, P. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900164 · Cited by 392
Induction of autoimmunity by pristane and other naturally occurring hydrocarbons
Reeves, W. H., Lee, P. Y., Weinstein, J. S., Satoh, M., & Lu, L. (2009) · Trends in Immunology · doi:10.1016/j.it.2009.06.003 · Cited by 392
Cited by
The microbiome in autoimmune diseases
De Luca, F., & Shoenfeld, Y. (2018) · Clinical and Experimental Immunology · doi:10.1111/cei.13158 · Cited by 510
Self-citationThe SARS-CoV-2 as an instrumental trigger of autoimmunity
Dotan, A., Muller, S., Kanduc, D., David, P., Halpert, G., & Shoenfeld, Y. (2021) · Autoimmunity Reviews · doi:10.1016/j.autrev.2021.102792 · Cited by 494
Self-citationWillhite, C. C., Karyakina, N. A., Yokel, R. A., Yenugadhati, N., Wisniewski, T. M., Arnold, I. M. F., Momoli, F., & Krewski, D. (2014) · Critical Reviews in Toxicology · doi:10.3109/10408444.2014.934439 · Cited by 412
Aluminum and Alzheimer's Disease: After a Century of Controversy, Is there a Plausible Link?
Tomljenovic, L. (2011) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-101494 · Cited by 370
Watad, A., De Marco, G., Mahajna, H., Druyan, A., Eltity, M., Hijazi, N., Haddad, A., Elias, M., Zisman, D., Naffaa, M. E., et al. (2021) · Vaccines · doi:10.3390/vaccines9050435 · Cited by 363
Self-citationInflammation as “common soil” of the multifactorial diseases
Scrivo, R., Vasile, M., Bartosiewicz, I., & Valesini, G. (2011) · Autoimmunity Reviews · doi:10.1016/j.autrev.2010.12.006 · Cited by 336
An Overview of Vaccine Adjuvants: Current Evidence and Future Perspectives
Facciolà, A., Visalli, G., Laganà, A., & Di Pietro, A. (2022) · Vaccines · doi:10.3390/vaccines10050819 · Cited by 316
Shaw, C. A., & Tomljenovic, L. (2013) · Immunologic Research · doi:10.1007/s12026-013-8403-1 · Cited by 269
Bondy, S. C. (2016) · NeuroToxicology · doi:10.1016/j.neuro.2015.12.002 · Cited by 263
Vaccines, adjuvants and autoimmunity
Guimarães, L. E., Baker, B., Perricone, C., & Shoenfeld, Y. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.08.003 · Cited by 262
Self-citationAluminum Vaccine Adjuvants: Are they Safe?
Tomljenovic, L., & A. Shaw, C. (2011) · Current Medicinal Chemistry · doi:10.2174/092986711795933740 · Cited by 211
Environmental Basis of Autoimmunity
Floreani, A., Leung, P. S. C., & Gershwin, M. E. (2016) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-015-8493-8 · Cited by 122
Chelating agents for human diseases related to aluminium overload
Crisponi, G., Nurchi, V. M., Bertolasi, V., Remelli, M., & Faa, G. (2012) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2011.06.013 · Cited by 103
Yavne, Y., Amital, D., Watad, A., Tiosano, S., & Amital, H. (2018) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2017.12.011 · Cited by 99
Macrophagic myofasciitis: characterization and pathophysiology
Gherardi, R., & Authier, F. (2012) · Lupus · doi:10.1177/0961203311429557 · Cited by 91
Principal Controversies in Vaccine Safety in the United States
DeStefano, F., Bodenstab, H. M., & Offit, P. A. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz135 · Cited by 86
Environmental Triggers of Autoreactive Responses: Induction of Antiphospholipid Antibody Formation
Martirosyan, A., Aminov, R., & Manukyan, G. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01609 · Cited by 62
Clinical Features in Patients with Long-Lasting Macrophagic Myofasciitis
Rigolet, M., Aouizerate, J., Couette, M., Ragunathan-Thangarajah, N., Aoun-Sebaiti, M., Gherardi, R. K., Cadusseau, J., & Authier, F. J. (2014) · Frontiers in Neurology · doi:10.3389/fneur.2014.00230 · Cited by 51
Metadata
- Authors
- Shoenfeld, Y., & Agmon-Levin, N.
- Venue
- Journal of Autoimmunity
- Publisher
- Elsevier BV
- Published
- 2011-02
- Volume
- 36
- Issue
- 1
- Pages
- 4-8
- ISSN
- 0896-8411 (ISSN-L)
- OpenAlex
- W2128269295
- Cited by
- 1,010
- References
- 41
- FWCI
- 63.97
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.